Expanded by IL-33, ILC2s in PC potentially produce chemokine CCL5, which promote the recruitment and accumulation of CD103+ DCs in tumor tissues and further activate antitumor immunity in CD8+T cells [117,124]. Here, IL33 is linked to neoplasm.